Humira® (Adalimumab), the world's best‐selling drug, constituted a major advance in rheumatoid arthritis (RA) therapy by neutralizing tumor necrosis factor‐alpha (TNFɑ) in the disease region.18, 19. Here, TNF is linked to rheumatoid arthritis.